Wall Street Analysts Think 10x Genomics (TXG) Could Surge 43.12%: Read This Before Placing a Bet

10x Genomics (TXG) closed the last trading session at $8.86, gaining 7.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 12.68 indicates a 43.1% upside potential.The mean estimate comprises 14 short-term price targets with a standard deviation of $3.05. While the lowest estimate of$ 6.50 indicates a 26.6% decline from the current price level, the most optimistic analyst expects t ...